Jeżeli nie znalazłeś poszukiwanej książki, skontaktuj się z nami wypełniając formularz kontaktowy.

Ta strona używa plików cookies, by ułatwić korzystanie z serwisu. Mogą Państwo określić warunki przechowywania lub dostępu do plików cookies w swojej przeglądarce zgodnie z polityką prywatności.

Wydawcy

Literatura do programów

Informacje szczegółowe o książce

Quinoxalines, Spplement 2 - ISBN 9780471264958

Quinoxalines, Spplement 2

ISBN 9780471264958

Autor: Desmond J. Brown, Edward C. Taylor, Jonathan A. Ellman

Wydawca: Wiley

Dostępność: 3-6 tygodni

Cena: 3 180,45 zł

Przed złożeniem zamówienia prosimy o kontakt mailowy celem potwierdzenia ceny.


ISBN13:      

9780471264958

ISBN10:      

0471264954

Autor:      

Desmond J. Brown, Edward C. Taylor, Jonathan A. Ellman

Oprawa:      

Hardback

Rok Wydania:      

2004-02-17

Ilość stron:      

510

Wymiary:      

240x163

Tematy:      

PN

This volume in the Chemistry of Heterocyclic Compounds series presents a comprehensive review of the quinoxaline literature from 1975 to the present (2002), updating Volumes 5 and 35. It provides an alphabetical table of known simple quinoxalines, including new compounds discussed in this volume and their physical data, as well as the pyrazines from the original volumes. Biological activities, spectral or other physical studies, and other such materials appear at appropriate points in the text. The in–depth coverage includes synthesis, reactions, spectroscopic, and physical properties for each class of compounds.
Chemistry of Heterocyclic Compounds, Volume 61: Supplement II provides the most up–to–date summation of knowledge of the synthetic chemistry of quinoxalines.

Spis treści:
CHAPTER 1: PRIMARY SYNTHESES.
1.1 From a Single Benzene Substrate.
1.1.1 By Formation of the N1, C8a Bond.
1.1.2 By Formation of the N1, C2 Bond.
1.1.2.1 Cyclization of o–(Ethylamino)aniline Derivatives.
1.1.2.2 Direct Cyclization of o–(Ethylamino)nitrobenzene Derivatives.
1.1.2.3 Reductive Cyclization of o–(Ethylamino)nitrobenzene Derivatives.
1.1.3 By Formation of the C2, C3 Bond.
1.2 From a Benzene Substrate with an Ancillary Synthon.
1.2.1 When the Synthon Supplies N1 of the Quinoxaline.
1.2.2 When the Synthon Supplies C2 of the Quinoxaline.
1.2.3 When the Synthon Supplies C2 + C3 of the Quinoxaline.
1.2.3.1 Using a Dialdehyde (Glyoxal) or Related Synthon.
1.2.3.2 Using an Aldehydo Ketone or Related Synthon.
1.2.3.3 Using an Aldehydo Acid or Related Synthon.
1.2.3.4 Using an Aldehydo Ester or Related Synthon.
1.2.3.5 Using an Aldehydo Amide, Nitrile, Acyl Halide, or Related Synthon.
1.2.3.6 Using a Diketone or Related Synthon.
1.2.3.7 Using a Keto Acid or Related Synthon.
1.2.3.8 Using a Keto Ester or Related Synthon.
1.2.3.9 Using a Keto Amide, Nitrile, Acyl Halide , or Related Synthon.
1.2.3.10 Using a Diacid (Oxalic Acid) as Synthon.
1.2.3.11 Using a Diester (a Dialkyl Oxalate) or Related Synthon.
1.2.3.12 Using an Estero Amide, Nitrile, Acyl Halide, or Related Synthon.
1.2.3.13 Using a Diamide (Oxamide), Amido Nitrile, or Related Synthon.
1.2.3.14 Using a Diacyl Dihalide (Oxalyl Halide) or Related Synthon.
1.2.4 When the Synthon Supplies N1 + C2 + C3 of the Quinoxaline.
1.2.5 When the Synthon Supplies N1 + C2 + C3 + N4 of the Quinoxaline.
1.3 From a Benzene Substrate with Two or More Synthons.
1.4 From a Pyrazine Substrate with or without Synthon(s).
1.5 From Other Heteromonocyclic Substrates/Synthons.
1.5.1 Azirines as Substrates/Synthons.
1.5.2 1,2,3–Dithiazol–1–iums as Substrates/Synthons.
1.5.3 Furans as Substrates/Synthons.
1.5.4 Isothiazoles as Substrates/Synthons.
1.5.5 Isoxazoles as Substrates/Synthons.
1.5.6 Oxazoles as Substrates/Synthons.
1.5.7 Oxirenes as Substrates/Synthons.
1.5.8 Pyrans as Substrates/Synthons.
1.5.9 Pyridazines as Substrates/Synthons.
1.5.10 Pyridines as Substrates/Synthons.
1.5.11 Pyrimidines as Substrates/Synthons.
1.5.12 Pyrroles as Substrates/Synthons.
1.5.13 Thiophenes as Substrates/Synthons.
1.5.14 1,2,4–Triazines as Substrates/Synthons.
1.5.15 1,2,3–Triazoles as Substrates/Synthons.
1.6 From Heterobicyclic Substrates/Synthons.
1.6.1 7–Azabicyclo[4.1.0]heptanes as Substrates/Synthons.
1.6.2 Benzimidazoles as Substrates/Synthons.
1.6.3 1,4–Benzodiazepines as Substrates/Synthons.
1.6.4 1,5–Benzodiazepines as Substrates/Synthons.
1.6.5 1–Benzopyrans (Chromenes) as Substrates/Synthons.
1.6.6 2,1,3–Benzoselena(or thia)diazoles as Substrates/Synthons.
1.6.7 2,1,3–Benzoxadiazoles as Substrates/Synthons.
1.6.8 Cycloheptapyrazines as Substrates/Synthons.
1.6.9 Indoles as Substrates/Synthons.
1.6.10 Pyrrolo[3,4–b]pyrazi nes as Substrates/Synthons.
1.7 From Heteropolycyclic Substrates/Synthons.
1.7.1 Azeto– or Azirino[1,2–a]quinoxalines as Substrates/Synthons.
1.7.2 Benz[g]indoles as Substrates/Synthons.
1.7.3 Benzo[3,4]cyclobuta[1,2–b]quinoxalines as Substrates/Synthons.
1.7.4 Benzo[g]pteridines as Substrates/Synthons.
1.7.5 [1]Benzopyrano[2,3–b]quinoxalines as Substrates/Synthons.
1.7.6 [1]Benzothiopyrano[4,3–b]pyrroles as Substrates/Synthons.
1.7.7 Cyclobuta[b]quinoxalines as Substrates/Synthons.
1.7.8 1,3–Dithiolo[4,5–b]quinoxalines as Substrates/Synthons.
1.7.9 1,4–Ethanoquinoxalines as Substrates/Synthons.
1.7.10 Furo[2,3–b]quinoxalines as Substrates/Synthons.
1.7.11 Furo[3,4–b]quinoxalines as Substrates/Synthons.
1.7.12 Indeno[1,2–b]pyrroles as Substrates/Synthons.
1.7.13 Isoxazolo[2,3–d][1,4]benzodiazepines as Substrates/Synthons.
1.7.14 Isoxazolo[2,3–a]quinoxalines as Substrates/Synthons.
1.7.15 [1,3,4]Oxadiazino[5,6–b]quinoxalines as Substrates/Synthons.
1.7.16 [1,2,4]Oxadiazolo[2,3–a]quinoxalines as Substrates/Synthons.
1.7.17 [1,2,5]Oxadiazolo[3,4–f]quinoxalines as Substrates/Synthons.
1.7.18 Phenazines as Substrates/Synthons.
1.7.19 Pyrazolo[3,4–b]quinoxalines as Substrates/Synthons.
1.7.20 Pyridazino[4,5–b]quinoxalines as Substrates/Synthons.
1.7.21 Pyrrolo[3,4–b]quinoxalines as Substrates/Synthons.
1.7.22 Quinoxalino[2,3–b]quinoxalines as Substrates/Synthons.
1.7.23 Thiazolo[2,3–b]benzothiazoliums as Substrates/Synthons.
1.7.24 Thiazolo[3,2–a]quinoxaliniums as Substrates/Synthons.
1.8 From Spiro Heterocyclic Substrates.
1.9 Glance Index to Typical Quinoxaline Derivatives Available by Primary Syntheses.
CHAPTER 2: QUINOXALINE, ALKYLQUINOXALINES, AND ARYLQUINOXALINES.
2.1 Quinoxaline.
2.1.1 Preparation of Quinoxaline.
2.1.2 Properties of Quinoxalin e.
2.1.3 Reactions of Quinoxaline.
2.2 Alkyl– and Arylquinoxalines.
2.2.1 Preparation of C–Alkyl– and C–Arylquinoxalines.
2.2.1.1 By Direct Alkylation or Arylation.
2.2.1.2 By Alkanelysis or Arenelysis of Halogenoquinoxalines.
2.2.1.3 From C–Formyl–, C–Aroyl–, C–Cyano–, or Oxoquinoxalines.
2.2.1.4 By Interconversion of Alkyl or Aryl Substituents.
2.2.1.5 By Elimination of Functionality from Substituted–Alkyl Substituents.
2.2.2 Preparation of N–Alkyl or N–Aryl Derivatives of Hydroquinoxalines.
2.2.3 Properties of Alkyl– and Arylquinoxalines.
2.2.4 Reactions of Alkyl– and Arylquinoxalines.
2.3 N–Alkylquinoxalinium Salts.
2.3.1 Preparation of N–Alkylquinoxalinium Salts.
2.3.2 Reactions of N–Alkylquinoxalinium Salts.
CHAPTER 3 HALOGENOQUINOXALINES.
3.1 Preparation of Nuclear Halogenoquinoxalines.
3.1.1 Nuclear Halogenoquinoxalines from Quinoxalinones.
3.1.2 Nuclear Halogenoquinoxalines by Direct Halogenation.
3.1.3 Nuclear Halogenoquinoxalines from Quinoxalinamines.
3.1.4 Nuclear Halogenoquinoxalines by Transhalogenation.
3.1.5 Nuclear Halogenoquinoxalines from Miscellaneous Substrates.
3.2 Reactions of Nuclear Halogenoquinoxalines.
3.2.1 Aminolysis of Nuclear Halogenoquinoxalines.
3.2.2 Hydrolysis, Alcoholysis, or Phenolysis of Nuclear Halogenoquinoxalines.
3.2.3 Thiolysis, Alkanethiolysis, Arenethiolysis, or Arenesulfinolysis of Nuclear Halogenoquinoxalines.
3.2.4 Azidolysis of Nuclear Halogenoquinoxalines.
3.2.5 Cyanolysis of Nuclear Halogenoquinoxalines.
3.2.6 Hydrogenolysis of Nuclear Halogenoquinoxalines.
3.2.7 Other Displacement Reactions of Nuclear Halogenoquinoxalines.
3.2.8 Cyclization Reactions of Nuclear Halogenoquinoxalines.
3.3 Preparation of Extranuclear Halogenoquinoxalines.
3.4 Reactions of Extranuclear Halogenoquinoxalines.
3.4.1 Aminolysis of Ext

Koszyk

Książek w koszyku: 0 szt.

Wartość zakupów: 0,00 zł

ebooks
covid

Kontakt

Gambit
Centrum Oprogramowania
i Szkoleń Sp. z o.o.

Al. Pokoju 29b/22-24

31-564 Kraków


Siedziba Księgarni

ul. Kordylewskiego 1

31-542 Kraków

+48 12 410 5991

+48 12 410 5987

+48 12 410 5989

Zobacz na mapie google

Wyślij e-mail

Subskrypcje

Administratorem danych osobowych jest firma Gambit COiS Sp. z o.o. Na podany adres będzie wysyłany wyłącznie biuletyn informacyjny.

Autoryzacja płatności

PayU

Informacje na temat autoryzacji płatności poprzez PayU.

PayU banki

© Copyright 2012: GAMBIT COiS Sp. z o.o. Wszelkie prawa zastrzeżone.

Projekt i wykonanie: Alchemia Studio Reklamy